The aim of this study was to investigate retinal and choriocapillaris vessel changes in diabetic macular edema (DME) after the intravitreal dexamethasone implant (IDI) using optical coherence tomography angiography (OCTA). Moreover, a comparison between morphological and functional parameters of DME and healthy patients was performed. Twenty-five eyes of 25 type 2 diabetic retinopathy patients complicated by macular edema (DME group) and 25 healthy subjects (control group) were enrolled. Superficial capillary plexus density (SCPD) and deep capillary plexus density (DCPD) in the foveal and parafoveal areas, choricapillary density (CCD) and optic disc vessel density (ODVD) were detected using OCTA at baseline and after 7, 30, 60, 90 and 120 d...
To assess and compare early changes in neuroinflammatory and vascular parameters in diabetic macular...
6noPurpose: To evaluate efficacy and safety of intravitreal dexamethasone 0.7 mg implant in treatmen...
Purpose. To evaluate efficacy and safety of intravitreal dexamethasone 0.7 mg implant in treatment-n...
The aim of this study was to investigate retinal and choriocapillaris vessel changes in diabetic mac...
Purpose: To evaluate the changes of retinal capillary nonperfusion areas and retinal capillary vesse...
To investigate changes in macular morphology and function after an intravitreal dexamethasone implan...
Background: The aim was to evaluate predictive value of baseline optical coherence tomography (OCT) ...
Purpose: Identification and characterization of patients with diabetic macular edema (DME) are impor...
Purpose. We aimed to assess the changes of retinal microvascular parameters using optical coherence ...
Purpose: To evaluate choroidal vascularity index (CVI) after a single dose of intravitreal dexametha...
Purpose: To analyse the effects of intravitreal dexamethasone implant (DEX) in patients with diabeti...
Purpose: To perform a longitudinal analysis of the effect of optic coherence tomography (OCT) biomar...
11noAIM: To investigate the efficacy and safety of ranibizumab (RZB group) and dexamethasone implant...
Objective. To evaluate macular perfusion changes following intravitreal bevacizumab injections for d...
International audienceIntroduction: Central vision loss due to diabetic macular edema (DME) is relat...
To assess and compare early changes in neuroinflammatory and vascular parameters in diabetic macular...
6noPurpose: To evaluate efficacy and safety of intravitreal dexamethasone 0.7 mg implant in treatmen...
Purpose. To evaluate efficacy and safety of intravitreal dexamethasone 0.7 mg implant in treatment-n...
The aim of this study was to investigate retinal and choriocapillaris vessel changes in diabetic mac...
Purpose: To evaluate the changes of retinal capillary nonperfusion areas and retinal capillary vesse...
To investigate changes in macular morphology and function after an intravitreal dexamethasone implan...
Background: The aim was to evaluate predictive value of baseline optical coherence tomography (OCT) ...
Purpose: Identification and characterization of patients with diabetic macular edema (DME) are impor...
Purpose. We aimed to assess the changes of retinal microvascular parameters using optical coherence ...
Purpose: To evaluate choroidal vascularity index (CVI) after a single dose of intravitreal dexametha...
Purpose: To analyse the effects of intravitreal dexamethasone implant (DEX) in patients with diabeti...
Purpose: To perform a longitudinal analysis of the effect of optic coherence tomography (OCT) biomar...
11noAIM: To investigate the efficacy and safety of ranibizumab (RZB group) and dexamethasone implant...
Objective. To evaluate macular perfusion changes following intravitreal bevacizumab injections for d...
International audienceIntroduction: Central vision loss due to diabetic macular edema (DME) is relat...
To assess and compare early changes in neuroinflammatory and vascular parameters in diabetic macular...
6noPurpose: To evaluate efficacy and safety of intravitreal dexamethasone 0.7 mg implant in treatmen...
Purpose. To evaluate efficacy and safety of intravitreal dexamethasone 0.7 mg implant in treatment-n...